SOM3355

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	4

8. ハンチントン病

臨床試験数 : 242 / 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159

trials per page:

Showing 1 to 4 of 4 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05475483 (ClinicalTrials.gov)	August 2, 2022	22/7/2022	Efficacy and Safety on SOM3355 in Huntington's Disease Chorea	Phase IIb, Randomized, Double-blind, Placebo-controlled Study in Parallel Groups Assessing the Effic ...	Huntington Chorea	Drug: SOM3355 capsules;Drug: Placebo capsules	SOM Innovation Biotech SA	NULL	Recruiting	21 Years	N/A	All	129	Phase 2	France;Germany;Italy;Poland;Spain;Switzerland;United Kingdom
2	EUCTR2021-003453-28-ES (EUCTR)	28/03/2022	30/12/2021	Phase IIb study assessing the efficacy and safety of two doses of SOM3355in patients suffering from ...	Phase IIb, randomized, double-blind, placebo-controlled study in parallel groups assessing the effic ...	Huntington’s Disease with choreic movements. MedDRA version: 20.0;Level: LLT;Classification code 100 ...	Trade Name: Calvan (bevantolol hydrochloride) Product Name: SOM3355(bevantolol hydrochloride) Product ...	SOM Innovation Biotech SA (SOM Biotech)	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	129	Phase 2	France;Poland;Spain;Germany;United Kingdom;Switzerland;Italy
3	NCT03575676 (ClinicalTrials.gov)	August 8, 2018	11/6/2018	Efficacy and Safety of SOM3355 in Huntington's Disease Chorea	Phase IIa, Double-blind, Randomized, Placebo-controlled Study of the Efficacy and Safety of SOM3355i ...	Huntington's Chorea	Drug: SOM3355 100mg BID;Drug: SOM3355 200mg BID;Drug: Placebo BID	SOM Biotech SL	NULL	Completed	18 Years	N/A	All	32	Phase 2	Spain
4	EUCTR2018-000203-16-ES (EUCTR)	18/06/2018	21/05/2018	Phase IIa, double-blind, randomized, placebo-controlled study of the efficacy and safety of SOM3335 ...	Phase IIa, double-blind, randomized, placebo-controlled study of the efficacy and safety of SOM3335 ...	Chorea movements associated with Huntington's Disease MedDRA version: 20.0;Level: LLT;Classification ...	Trade Name: Calvan® 100 mg INN or Proposed INN: BEVANTOLOL HYDROCHLORIDE	SOM Biotech	NULL	Not Recruiting			Female: yes Male: yes	30	Phase 2	Spain

First Previous1Next Last